News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
413,730 Results
Type
Article (21875)
Company Profile (146)
Press Release (391697)
Multimedia
Podcasts (115)
Webinars (20)
Section
Business (128826)
Career Advice (1428)
Deals (22478)
Drug Delivery (97)
Drug Development (44408)
Employer Resources (145)
FDA (8682)
Job Trends (9970)
News (210333)
Policy (19229)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1036)
Accelerated approval (19)
Adcomms (11)
Allergies (79)
Alliances (33605)
ALS (76)
Alzheimer's disease (802)
Antibody-drug conjugate (ADC) (167)
Approvals (8843)
Artificial intelligence (386)
Autoimmune disease (68)
Automation (28)
Bankruptcy (193)
Best Places to Work (7366)
BIOSECURE Act (19)
Biosimilars (129)
Biotechnology (74)
Bladder cancer (79)
Brain cancer (34)
Breast cancer (273)
Cancer (2239)
Cardiovascular disease (217)
Career advice (1221)
Career pathing (31)
CAR-T (124)
CDC (24)
Cell therapy (367)
Cervical cancer (20)
Clinical research (38543)
Collaboration (1113)
Company closure (1)
Compensation (446)
Complete response letters (38)
COVID-19 (1208)
CRISPR (59)
C-suite (664)
Cystic fibrosis (87)
Data (2845)
Decentralized trials (1)
Denatured (46)
Depression (63)
Diabetes (227)
Diagnostics (3298)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (32)
Drug discovery (179)
Drug pricing (169)
Drug shortages (19)
Duchenne muscular dystrophy (99)
Earnings (46366)
Editorial (52)
Employer branding (17)
Employer resources (121)
Events (61987)
Executive appointments (814)
FDA (10343)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (7)
Frontotemporal dementia (12)
Funding (782)
Gene editing (106)
Generative AI (41)
Gene therapy (316)
GLP-1 (610)
Government (2436)
Grass and pollen (4)
Guidances (275)
Healthcare (8395)
HIV (25)
Huntington's disease (18)
IgA nephropathy (40)
Immunology and inflammation (111)
Immuno-oncology (22)
Indications (66)
Infectious disease (1330)
Inflammatory bowel disease (96)
Inflation Reduction Act (13)
Influenza (53)
Intellectual property (149)
Interviews (230)
IPO (8866)
IRA (53)
Job creations (2839)
Job search strategy (1030)
JPM (49)
Kidney cancer (13)
Labor market (75)
Layoffs (297)
Leadership (27)
Legal (4536)
Liver cancer (39)
Longevity (9)
Lung cancer (350)
Lymphoma (184)
Machine learning (32)
Management (45)
Manufacturing (624)
MASH (106)
Medical device (5639)
Medtech (5664)
Mergers & acquisitions (14347)
Metabolic disorders (673)
Multiple sclerosis (67)
NASH (16)
Neurodegenerative disease (156)
Neuropsychiatric disorders (49)
Neuroscience (1413)
Neurotech (1)
NextGen: Class of 2026 (3762)
Non-profit (1672)
Now hiring (31)
Obesity (330)
Opinion (264)
Ovarian cancer (79)
Pain (131)
Pancreatic cancer (87)
Parkinson's disease (138)
Partnered (24)
Patents (304)
Patient recruitment (191)
Peanut (18)
People (44874)
Pharmaceutical (68)
Pharmacy benefit managers (27)
Phase 1 (10462)
Phase 2 (16499)
Phase 3 (14323)
Pipeline (2873)
Policy (243)
Postmarket research (1557)
Preclinical (4393)
Press Release (59)
Prostate cancer (118)
Psychedelics (25)
Radiopharmaceuticals (195)
Rare diseases (508)
Real estate (4235)
Recruiting (62)
Regulatory (14645)
Reports (39)
Research institute (1146)
Resumes & cover letters (232)
Rett syndrome (8)
RNA editing (7)
RSV (27)
Schizophrenia (88)
Series A (136)
Series B (95)
Service/supplier (4)
Sickle cell disease (61)
Special edition (19)
Spinal muscular atrophy (110)
Sponsored (28)
Startups (2444)
State (2)
Stomach cancer (7)
Supply chain (77)
Tariffs (91)
The Weekly (67)
Vaccines (377)
Venture capital (66)
Weight loss (206)
Women's health (53)
Worklife (16)
Date
Last 7 days (290)
Last 30 days (1120)
Last 365 days (16289)
2026 (1505)
2025 (16696)
2024 (19554)
2023 (22362)
2022 (30714)
2021 (32076)
2020 (30864)
2019 (27753)
2018 (21176)
2017 (20047)
2016 (19142)
2015 (22363)
2014 (17456)
2013 (14964)
2012 (16506)
2011 (17103)
2010 (15055)
Location
Africa (517)
Alabama (33)
Alaska (5)
Arizona (144)
Arkansas (5)
Asia (28710)
Australia (3885)
California (5464)
Canada (2024)
China (720)
Colorado (232)
Connecticut (244)
Delaware (166)
Europe (56403)
Florida (927)
Georgia (145)
Hawaii (3)
Idaho (33)
Illinois (602)
India (48)
Indiana (332)
Iowa (16)
Japan (306)
Kansas (98)
Kentucky (30)
Louisiana (17)
Maine (17)
Maryland (660)
Massachusetts (4027)
Michigan (191)
Minnesota (311)
Mississippi (4)
Missouri (60)
Montana (13)
Nebraska (22)
Nevada (58)
New Hampshire (51)
New Jersey (1881)
New Mexico (13)
New York (1631)
North Carolina (938)
North Dakota (8)
Northern California (2587)
Ohio (180)
Oklahoma (13)
Oregon (24)
Pennsylvania (1107)
Puerto Rico (13)
Rhode Island (31)
South America (808)
South Carolina (33)
Southern California (2180)
Tennessee (87)
Texas (793)
United States (20697)
Utah (123)
Vermont (1)
Virginia (196)
Washington D.C. (58)
Washington State (361)
West Virginia (4)
Wisconsin (76)
Wyoming (1)
413,730 Results for "sun pharmaceutical industries".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
January 16, 2026
·
8 min read
Mergers & acquisitions
At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun
Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a break after a few tough years.
January 9, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®
November 13, 2025
·
4 min read
Press Releases
Sun Pharma Announces Jeremy Allen as Vice President, Corporate Affairs for North America
October 23, 2025
·
3 min read
Deals
Sun Pharma Completes Taro Merger
Sun Pharmaceutical Industries Limited today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) with its subsidiary.
June 24, 2024
·
1 min read
Deals
Taro Shareholders Approve Merger with Sun Pharma
Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. announced that the merger agreement between Taro and Sun Pharma was approved by the affirmative vote of Taro shareholders at an Extraordinary General Meeting and an Ordinary Class Meeting on May 22, 2024.
May 23, 2024
·
4 min read
Press Releases
Sun Pharma Announces Appointment of Richard Ascroft as CEO North America
June 26, 2025
·
3 min read
Business
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
Terns Pharmaceuticals, Inc. announced the appointment of Melita Sun Jung as chief business officer, effective April 22, 2024.
April 10, 2024
·
5 min read
Deals
Taro Announces Merger Agreement with Sun Pharma
Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. announced that they have entered into a definitive merger agreement in which Sun Pharma, Taro’s controlling shareholder, has agreed to acquire all of the outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliates for US$43.00 per share in cash without interest.
January 17, 2024
·
8 min read
Press Releases
Sun Pharma Completes its Acquisition of Checkpoint Therapeutics
May 30, 2025
·
10 min read
1 of 41,373
Next
